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Abstract
The kinetics of apolipoprotein (apo) B-100 in particles containing
apo E (B,E particles) or lacking apo E (B particles) were studied
in Watanabe heritable hyperlipidemic (WHHL) rabbits deficient
in low density lipoprotein (LDL) receptors, and compared with
those of normal rabbits after injection of radioiodinated very low
density lipoproteins (VLDL), intermediate density lipoproteins
(IDL), and LDL. In both groups results of kinetic modeling were
consistent with the hypothesis that all apo B enters the plasma
in VLDL, mainly as BE particles, followed by delipidation and
partial conversion to IDL and LDL, with concomitant conversion
of some B,E particles to B particles. In WHHL rabbits, pro-
duction ofVLDL apo B was reduced by 40%, but LDL production
was increased threefold. Defective removal ofBE and B particles
in all three lipoprotein classes, coupled with preserved processes
of delipidation, can account for the observed increases in the
concentration of apo B (threefold in VLDL, fivefold in IDL, and
twenty-twofold in LDL) in WHHL rabbits.
Introduction
The discovery of a mutant rabbit model of human familial hy-
percholesterolemia, in which low density lipoprotein (LDL) re-
ceptors are grossly deficient (the Watanabe heritable hyperlipi-
demic [WHHL]' rabbit), has increased the usefulness of this
species for the study oflipoprotein metabolism. In these animals,
the concentration of very low density lipoproteins (VLDL) and
intermediate density lipoproteins (IDL) as well as that of LDL
is increased (1). Metabolic studies inWHHL rabbits have shown
that the rate of irreversible disposal ofVLDL (2) as well as that
ofLDL (3, 4) is impaired, whereas that ofchylomicrons is normal
(5). As in normal rabbits virtually all apolipoprotein (apo) B-
100 has been shown to appear in liver perfusates of WHHL
rabbits as VLDL, and the rate of accumulation of apo B is not
increased in these perfusates (6). These observations, together
with the finding that the fraction of VLDL converted to LDL
is increased in WHHL rabbits (2), have led to several important
conclusions: (a) chylomicron remnants are taken up into the
liver by a receptor genetically distinct from the LDL receptor;
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(b) receptor deficiency increases LDL levels by increasing LDL
formation as well as by reducing its catabolism; (c) the increased
formation ofLDL associated with receptor deficiency is not ex-
plained by increased secretion ofVLDL or de novo secretion of
lipoproteins of higher density, but rather by an increased frac-
tional conversion of VLDL to LDL; and (d) the LDL receptor
is normally responsible for the direct uptake ofVLDL remnants.
These conclusions are of particular interest because the rabbit
resembles the human with respect to some fundamental char-
acteristics of lipoprotein metabolism, including the secretion of
a single species ofapo B (B- 100) by the liver (6) and the presence
of an active mechanism for transfer of cholesteryl esters and
triglycerides among lipoprotein particles (7-9).
The conclusions that have been reached about the effect of
LDL receptor deficiency on the metabolism oflipoproteins con-
taining apo B-I00 in rabbits have remained qualitative because
methods to deal with the structural and metabolic heterogeneity
oflipoproteins in this species have not been developed. We have
recently reported the application of a new kinetic approach to
the analysis of lipoprotein heterogeneity and its use to quantify
the rate of secretion of apo B-100 and its subsequent metabolic
fate in normal New Zealand White (NZW) rabbits (10). Our
data indicate that all the major lipoprotein classes that contain
apo B-100 are heterogeneous with respect to content of apo E,
and include particles that contain apo E (B,E particles) as well
as particles that lack apo E (B particles). The presence of apo E
in VLDL particles was shown to have a major influence on the
rate of irreversible disposal of component apo B and its con-
version to lipoproteins of higher density, IDL and LDL.
The evident influence ofapo E upon lipoprotein metabolism
in rabbits is of particular interest because this protein, like apo
B- 100, is a ligand for the LDL receptor (1 1, 12). The lack of
LDL receptors should therefore influence the metabolism of B,E
particles as well as that of B particles.
We have carried out experiments in WHHL homozygotes,
comparable with those that we have reported for NZW rabbits,
to test various hypotheses concerning the influence ofLDL re-
ceptor deficiency upon the metabolism oflipoproteins containing
apo E as well as apo B-100 and to quantify the effect of receptor
deficiency on rates of lipoprotein interconversions and irrevers-
ible disposal. Our results confirm previous qualitative conclu-
sions, yield quantitative estimates ofthe secretion ofVLDL par-
ticles and their conversion to IDL and LDL, and provide fresh
insights into the nature of the kinetic heterogeneity seen in all
classes of lipoproteins containing apo B. In addition, our obser-
vations suggest that some VLDL particles are removed from the
blood ofWHHL rabbits by high affinity mechanisms.
Methods
Animals. Male WHHL rabbits weighing 2.4-3.3 kg and male NZW rab-
bits weighing 2.3-2.8 kg were used for experiments in intact animals.
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All animals were fed lab rabbit chow (Ralston Purina Co., St. Louis,
MO). Before and during in vivo experiments, the animals were kept in
individual cages (10). For liver perfusions, two WHHL rabbits (liver
weights 95 and 110 g) and two NZW rabbits (liver weights 91 and 95 g)
were used.
Preparation oflipoproteins. The preparation of lipoproteins for ex-
periments on NZW rabbits has been described (10). For experiments on
WHHL rabbits, 10 ml of blood was withdrawn from an ear vein 4-5 d
before in vivo experiments and mixed with disodium EDTA (1 mg/ml),
sodium azide (0.2 mg/ml), and gentamycin (10 Mg/ml), pH 7.4. Lipo-
proteins were isolated from plasma by sequential ultracentrifugation at
45,000 rpm in a Beckman ultracentrifuge (50.2 rotor) at 12'C as follows:
VLDL (d < 1.006 g/ml) for 16 h; IDL (1.006 < d < 1.109 g/ml) for 18
h; and LDL (1.019 < d < 1.063 g/ml) for 20 h. Lipoproteins used for
iodination were recentrifuged at 39,000 rpm in a 40.3 rotor at 12'C for
20 h, then dialyzed against 0.15 M NaCl containing 0.01% disodium
EDTA, 0.02% sodium azide, pH 7.4, and iodinated with 125I (Pharmacia
Fine Chemicals, Uppsala, Sweden) or 1311 (ICN Biochemicals, Irvine,
CA) by a modification ofthe method ofMcFarlane (13, 14) to a specific
activity of 110-550 dpm/ng protein. Free iodine was removed on a col-
umn (1 X 10 cm) of Sephadex G-50 (Pharniacia Fine Chemicals). As
determined by assay ofcomponents separated by sodium dodecyl sulfate
gel electrophoresis, at least 90% of the apo El of VLDL was in apo B-
100. The percentage oftotal radioiodine in apo B, measured as radioiodine
insoluble in 50% isopropranol, was - 51, 83, and 79% in VLDL, IDL,
and LDL, respectively. The labeled lipoprotein (0.5-1 mg protein) was
mixed with 1 ml ofautologous plasma and dialyzed twice against 4 liters
of 0.15 M NaCl containing 0.01% disodium EDTA, 0.02% sodium azide,
and gentamycin (5 sg/ml), pH 7.4, at 4°C. Before injection into animals,
iodinated lipoproteins were dialyzed against 0.15 M NaCl for 1-2 h and
passed through a 0.22-Mm filter (Gelman Sciences, Inc., Ann Arbor, MI).
VLDL were also separated from some samples of fresh plasma on a 2
X 90-cm column of 6% agarose (Biogel A-5 M; Bio-Rad Laboratories,
Richmond, CA) (15) to compare their composioion with that of ultra-
centrifuged VLDL. 2 to 3 ml of plasma was applied to the column.
Elution was at 10 ml/h with 0.15 M NaCl containing disodium EDTA
(0.01%) and sodium azide (0.02%), pH 7.4.
Lipoprotein kinetics in vivo. For experiments in NZW rabbits, li-
poproteins from donor animals were injected into recipients obtained
at the same time from the supplier. For experiments with WHHL rabbits,
autologous lipoproteins were used. Two lipoprotein fractions labeled with
a different isotope ofiodine (30-60 MCi each) were injected simultaneously
into an ear vein ofunanesthetized animals at - 9:00 a.m. Blood samples
of 2 ml were taken from an opposite ear vein into a tube containing 2
mg disodium EDTA and 0.4 mg sodium azide 3, 30, 90, 180, 360, 720,
1,440, and, in WHHL rabbits, 2,160 min after injection and placed on
ice. Pla]ma was separated by centrifugation at 4°C.
Immunoaf/inity chromatography. Antiserum to rabbit apo E was
produced in a sheep (1). Specific antibodies against apo E were separated
from 40 ml of antiserum on a rabbit apo E-Sepharose affinity column
(1 X 6 cm) containing 8 mg ofapo E (16). The bound fraction from the
column (40-140 mg of purified antibody) was coupled to CNBr-activated
Sepharose 4B (Pharmacia Fine Chemicals). This immunoaffinity column
(1 X 10 cm), equilibrated with 0.15 M NaCl containing disodium EDTA
(0.01%) and sodium azide (0.02%), pH 7.4 (buffer A), and maintained
at 4°C, bound at least 20 Mug ofapo E. Whole plasma (0.02-0.1 ml) was
applied to the column and the unbound material was eluted at 2 ml/h
for 1 h, 20 ml/h for 30 min, and finally 40 ml/h for 1 h. This fraction
contained no immunoassayable apo E. The bound lipoproteins were
then eluted with 30 ml of 3 M NaSCN containing bovine serum
albumin (1 mg/ml), pH 7.4, at a rate of 40 ml/h. Columns were im-
mediately reequilibrated with buffer A and could be used several hundred
times, with gradual loss ofbinding capacity.
Measurement of radioactivity and mass of apo B. Radioiodine in
apo B of plasma and in the fraction that did not bind to the immu-
noaffinity column (B particles) was measured as described (10, 17). Ra-
dioiodine in apo B of lipoproteins boend to the column (B,E particles)
was determined by subtracting radioactivity in apo B of the unbound
fraction from that in original whole plasma.
The concentration of apo B in VLDL, IDL, and LDL in each ex-
perimental animal was determined on pools ofplasma obtained between
3 min and 6 h after uptake of radioiodinated lipoproteins. The content
of radioiqdine (derived from the injected 125I- or '311-apo B) in VLDL,
IDL, and LDL separated by sequential ultracentrifugation was measured
as described above. The specific activity ofapo B in these fractions (which
had been recentrifuged to remove contaminating plasma proteins) was
determined as described (10). The concentration of apo B in each lipo-
protein fraction was calculated by dividing the concentration of ra-
dioiodine in apo B by its specific activity (10).
Lipid and protein analysis. Total cholesterol and triglyceride con-
centrations in plasma were measured by an automated technique (18).
Concentration ofapo E in plasma and lipoprotein fractions was measured
by radioimmunoassay (1).
Liverperfusion. 1-1.5 mCi of [3H]lysine (40 mCi/mmol, Amersham
Corp., Arlington Heights, IL) was injected into NZW or WHHL rabbits
30 min before perfusion and the liver was perfused with 3 mCi of
[3Hflysine for 30-60 min in a recirculating system, then flushed with
nonradioactive perfusate for 3-4 min (150 ml). Perfusate was then col-
lected for 30 min in a non-recirculating system and finally for an ad-
ditional 30 min in a recirculating system (6). Samples of single-pass per-
fusates were applied to the anti-E affinity column and content of 3H in
B and B,E particles was determined by liquid scintillation spectrometry
in aquasol (NEN Research Products, Boston, MA). Samples of recir-
culating perfusates were separated by density gradient ultracentrifugation,
as described below.
Density gradient centrifugation. This procedure was modified from
one described previously (19). Three solutions ofincreasing density were
layered into a Beckman centrifuge tube (1.3 X 6.4 cm): 2.0 ml of water,
2.1 ml of 0.64 M NaCl (d = 1.025 g/ml); and 2.1 ml of 1.28 M NaCl (4
= 1.050 g/ml). Densities ofliver perfusate samples were adjusted to 1.05
and 1.025 g/ml and used to form the lower two layers of the gradient.
The sample was centrifuged in a Beckman SW 41 rotor at 39,000 rpm
for 22 h at 120C. The top fraction (0.5 ml) was obtained by tube slicing
and the tube wall was rinsed with 0.5 ml of water. Then, 11 fractions
(0.5 ml/fraction) were obtained sequentially by aspiration at the meniscus
with an automatic pipette (Pipetman; Gilson Medical Electronics, Inc.,
Middleton, WI). The density ofeach fraction was measured with a con-
ductivity meter and content of radioiodine in apo B was determined as
above.
Kinetic analysis. Content ofapo B in B,E and B particleswas measured
in whole plasma in six experiments each for VLDL, IDL, and LDL
injections into WHHL rabbits. The averaged data were analyzed in a
fashion similar to that already used in similar experiments on normal
NZW rabbits (10). Briefly, this analysis took the form offirst developing
a model describing the kinetics ofplasma B,E and B particles after LDL
injection. The same analysis was again performed for injections ofIDL
and VLDL. By initially assuming the LDL model to be known for analysis
ofthe IDL model and the LDL and IDL models to be known for analysis
of the VLDL model, good estimates of the parameters of the three sub-
systems of the combined model were possible using only whole plasma
B,E and B particle data. In the final parameter fitting procedure all ad-
justable parameters were fitted to all the data at the same time, using
the time interrupt feature of the SAAM 27 program (20, 21).
The following additional constraints were imposed upon the modeling
process to test various hypotheses relating the kinetics ofapo B transport
in the WHHL rabbit to those in the normal rabbit. For the WHHL
model all six fractional rates ofirreversible loss (from B,E and B particles
in VLDL, IDL, and LDL) were initially assumed equal, the hypothesis
being that apo E had no significant effect on irreversible loss in these
animals that have little if any LDL receptor activity. This hypothesis
was inconsistent with the data. The fractional rate of irreversible loss of
B,E particles from VLDL had to be greater than that of the other live
groups of particles; it was consequently made independently adjustable.
Extravascular kinetics of B,E and B particles in LDL and IDL were
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assumed equal and invariant between normal and WHHL rabbits. This
assumption was based on the fact that particle size in both density ranges
in both normal and WHHL rabbits is similar (1). The fractional rates
of conversion of IDL B,E particles to LDL B,E particles were assumed
equal in normal and WHHL rabbits, as were the comparable rates for
B particles. In VLDL the fractional rates of conversion of B,E and B
particles to IDL B,E and B particles, respectively, were assumed equal
in WHHL rabbits (the hypothesis that these fractional conversion rates
were the same in normal and WHHL rabbit was inconsistent with the
data). The fractional rates of conversion of B,E particles to B particles
in both IDL and LDL were assumed to be equal.
Two additional constraints were imposed on the model previously
published for normal rabbits (10). The fractional rates of conversion of
VLDL B,E and B particles to IDL B,E and B particles, respectively, were
assumed equal. This hypothesis, which fit the data well, was not tested
in our published model. The fractional rate of conversion of LDL B,E
particles to B particles was poorly determined because of the low rate of
transport of both mass and radioactivity along this pathway using the
model configuration adopted here (10). Since this pathway was well de-
termined in the WHHL model, this parameter in the normal model was
set equal to that in the WHHL model, a hypothesis that fitted the data
well.
Of the 40 rate constants in both models, 27 were assumed dependent,
leaving 13 adjustable parameters. These parameters were adjusted iter-
atively at the same time to the 18 sets of average tracer data (plasma
B,E, B, and total apo B radioactivity from LDL, IDL, and VLDL injec-
tions in both normal and WHHL rabbits) using the SAAM 27 computer
program. The fitting procedure was further constrained by assuming that
all apo B production occurs in the VLDL density range. The IDL and
LDL B,E and B masses in both normal and WHHL rabbits were weighted
in the steady state solution and used to constrain the fitting of the tracer
data. The statistical uncertainties of the adjustable parameters were es-
timated from the variance-covariance matrix at the least-squares fit.
Results
Lipoprotein-lipid and protein concentrations and distributions.
In this and the following section, the data from not only WHHL
rabbits but also NZW rabbits, some ofwhich have been reported
previously (1, 10), are compared. Concentrations of lipids, apo
B, and apo E in plasma are shown in Table I. At the beginning
and end of the experiments in WHHL rabbits, the mean plasma
total cholesterol concentrations were 561 and 520 mg/dl, re-
spectively; corresponding plasma triglyceride values were 415
and 378 mg/dl (n = 9). Plasma lipid values in 13 NZW rabbits
have been reported elsewhere (10). All values were manyfold
higher in WHHL rabbits than in NZW rabbits, but the molar
ratio of apo E to apo B was close to 1:1 in both. The content of
apo B and apo E in ultracentrifugally separated VLDL, IDL,
and LDL is shown in Table II. In WHHL rabbits the mean E/
B ratio was 2.58 in VLDL, 1.23 in IDL, and 0.25 in LDL. Cor-
responding values for NZW rabbits were 2.25, 0.56, and 0.21.
In lipoproteins separated from two pools of plasma from WHHL
rabbits by gel filtration chromatography, E/B ratios were 2.16
and 3.16 in VLDL, 0.92 and 0.87 in IDL, and 0.42 and 0.57 in
LDL; corresponding values were 2.8, 0.58, and 0.32, respectively,
in one pool from NZW rabbits. Thus, for fractions separated by
sequential centrifugation or gel permeation chromatography, the
E/B ratio of VLDL in WHHL and NZW rabbits was similar,
but in IDL the ratio was higher in WHHL than in NZW rabbits.
The concentration of apo B in lipoprotein fractions was
measured in the nineWHHL rabbits used for in vivo experiments
in which two labeled lipoprotein fractions were injected simul-
taneously (Table III). Of the 197 mg/dl ofapo B in plasma, 16%
Table I. Plasma Lipid and Apoprotein Concentrations
in NZW and WHHL Rabbits
NZW* WHHL
mg/dl mg/dl
Total cholesterol 45±14 561±204
Triglycerides 77±38 415±145
Apo B 25** 197±30
Apo E 1.8±0.3 10.2±2.6
Molar ratio E/BO 1.12 0.93
Values are mean±SD for 8-13 animals.
* From references 1 and 10.
$Mean of two groups of animals (n = 6 and n = 8).
§ Based on M, for apo B of 550,000 and for apo E of 34,000.
was in VLDL, 23% in IDL, and 60% in LDL (values in NZW
rabbits were 25 mg/dl in plasma, ofwhich 42, 37, and 22% were
in VLDL, IDL, and LDL, respectively). The concentration of
apo B in B and B,E particles in each ofthese lipoprotein fractions
was calculated from the distribution of labeled apo B between
B,E and B particles in the VLDL, IDL, and LDL injected in the
kinetic experiments (Table III). This calculation was based on
the observation that the specific activity of apo B in the total
lipoprotein fraction and in the B particles separated by immu-
noaffinity chromatography differed by only 0-9%. In WHHL
rabbits, the percentage ofapo B in B,E particles was 88 in VLDL,
88 in IDL, and 57 in LDL. Each of these values exceeded that
found in NZW rabbits (75, 51, and 15%, respectively). Based
upon these values for the fraction of total apo B in B,E particles
and the E/B ratios found for each lipoprotein fraction (Table
II), it can be estimated that the average number of apo E mol-
ecules in B,E particles for VLDL, IDL, and LDL, respectively,
was 2.9, 1.4, and 0.44 in WHHL rabbits and 3.0, 1.1, and 1.4
in NZW rabbits. The low average number of apo E molecules
in BE particles of LDL from WHHL rabbits may reflect ultra-
centrifugal dissociation of apo E. This possibility is supported
by the observation that the E/B ratio in LDL obtained by gel
permeation chromatography from WHHL rabbits was about
twice that for ultracentrifuged LDL, as noted above. Evidently,
the procedure of incubating the injected lipoproteins with au-
tologous plasma led to reacquisition of the dissociated apo E.
Similarly, the majority, but not all, ofapo B in newly secreted
lipoproteins in perfusates of liver from NZW or WHHL rabbits
was in B,E particles (Table IV). Virtually no labeled apo B was
Table II. Apoprotein Composition ofRabbit Plasma Lipoproteins
NZW WHHL
VLDL IDL LDL VLDL IDL LDL
Total protein (%)
Apo B 40.9 72.7 91.3 46.4 73.9 84.0
Apo E 5.7 2.5 1.2 7.4 5.6 1.3
Molar ratio
E/B* 2.25 0.56 0.21 2.58 1.23 0.25
Values are mean for six NZW and six WHHL rabbits.
* Based on M, for apo B of 550,000 and for apo E of 34,000.
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Table III. Concentration ofapo B-100 in Plasma Lipoproteins
ofNZWand WHHL Rabbits
Total B,E particles B particles
NZW WHHL NZW* WHHLt NZW* WHHLT
mg/dl mg/dl mg/dl mg/dl mg/dl mg/dl
VLDL 10.5 32.5 7.9±1.0 28.5±1.3 2.6±1.0 4.0±1.2
IDL 9.3 46.0 4.7±1.4 40.4±2.3 4.6±1.4 5.6±2.2
LDL 5.5 118.7 0.8±0.27 67.3±16.1 4.7+0.33 51.4±16.3
* Mean±SD (n = 5-8).
tMean±SD (n = 6).
found in perfusate lipoprotein fractions with densities exceeding
1.005 g/ml in these experiments (Table V).
Lipoprotein kinetics. The kinetics of removal from whole
plasma of radioiodine in total apo B injected as VLDL, IDL,
and LDL are shown in Fig. 1, together with the model-generated
fits to the data for both NZW and WHHL rabbits. It is clear
that the rates of disappearance of apo B from whole plasma of
WHHL rabbits were considerably slower than those seen inNZW
rabbits for all fractions injected. The rate of disappearance was
greater after VLDL injection than after IDL and LDL injections
in both groups. The fits of the model for NZW and WHHL
rabbits to the data for B,E and B particles are shown in Figs. 2
and 3. The rates of disappearance of B,E particles from plasma
were faster than those of B particles for all injections, but the
magnitude of differences was greater in NZW rabbits.
The rate constants (h-'), transports (mg. dl-I h'), and
calculated masses (mg. dlE') for NZW and WHHL rabbits
are shown in Figs. 4 and 5. All rate constants were well deter-
mined with fractional standard deviations <0.10, with the
exception of the two rate constants describing extravascular
kinetics. These two constants had an average fractional standard
deviation of 0.19.
The fractional rate ofirreversible loss ofVLDL B,E particles
from plasma ofWHHL rabbits was four times greater than that
of VLDL B particles. However, this rate was only 10% of
that for VLDL B,E particles in NZW rabbits. The fractional
rates of loss ofLDL B,E and B particles in WHHL rabbits were
- 10 and 15%, respectively, of those in NZW rabbits.
The total production rate of apo B in VLDL of WHHL
rabbits was - 60% of that in NZW rabbits (4.83 vs. 7.96
mg. dl' * h-). Conversely, the production rate of LDL apo B
in WHHL rabbits exceeded that of NZW rabbits by almost a
Table IV. Distribution of[3H]Lysine-labeled apo B in B and B,E
Particles in Lipoproteins ofLiver Perfusates
NZW WHHL
Exp. %B %B,E %B %BE
1 32.1 67.9 25.4 74.6
2 22.9 77.1 42.9 57.1
[3HJLysine was injected into donor animals and added to perfusates,
as described in Methods. Values for each experiment are means of
three samples obtained after 5, 10, and 15 min of single-pass perfu-
sions.
Table V. Distribution of[3H]Lysine-labeled apo B in Density
Gradient Ultracentrifugal Fractions ofLiver Perfusates
Apo B
Gradient fractions NZW WHHL
Mean density±SD Exp. 1 Exp. 2 Exp. 1 Exp. 2
Wm % % % %
1.0047+0.0005 95.5 93.8 98.2 98.3
1.0068±0.0006 1.6 2.0 0.3 0.1
1.0105±0.0011 0.9 1.6 0.3 0.2
1.0136+0.0009 1.0 1.1 0.1 0.1
1.0184±0.0006 0.8 1.0 0.7 0.3
1.0224±0.0007 0.2 0.5 0 0.2
> 1.0275±0.0008 0.1 0 0.5 0.8
Perfusates were obtained after 30 min of recycling perfusion.
factor of 3 (1.95 vs. 0.67 mg dl- *h.-'). This increase in apo B
production in LDL of WHHL rabbits, in combination with a
fractional catabolic rate for LDL apo B of only - 15% that
found in NZW rabbits, accounts for the 22-fold increase in LDL
apo B mass ofWHHL rabbits as compared with that ofNZW
rabbits.
The calculated percentage conversions for total apo B and
apo B in B,E and B particles between lipoprotein fractions are
shown in Table VI. For total apo B in WHHL rabbits, 56% of
VLDL was converted to IDL and 72% ofIDL to LDL, yielding
an overall conversion of VLDL to LDL of 40%. By contrast,
overall conversion of VLDL to LDL in NZW rabbits was only
8%. The percentage conversion ofVLDL B,E particles to LDL
B,E particles was only 2% in NZW rabbits as compared with a
value > 15 times greater (31%) inWHHL rabbits. The percentage
conversions for B particles from VLDL to LDL were 29 and
74% in NZW and WHHL rabbits, respectively.
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Figure 1. Removal from whole plasma of total apo B after injection of
homologous radioiodinated lipoproteins into NZW rabbits and auto-
logous radioiodinated lipoproteins into WHHL rabbits. Mean values
in NZW rabbits are shown for five experiments with VLDL and eight
experiments with IDL and LDL. For WHHL rabbits, mean values for
six experiments with each lipoprotein fraction are shown. The curves
were derived from kinetic analysis of the data using the model solu-
tions shown in Figs. 4 and 5.
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ilarity oflipoprotein metabolism in NZW andWHHL rabbits-
essentially all apo B is secreted in particles with a density < 1.006
g/ml (i.e., VLDL). Previously, it was shown that virtually all
newly synthesized apo B in liver perfusates from NZW and
WHHL rabbits has a density < 1.010 g/ml (6). Our current find-
ings, based upon density gradient ultracentrifugation of liver
perfusates, indicate that < 2% of newly synthesized apo B is
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Figure 2. Removal from whole blood plasma of apo B in B,E and B
particles after injection of homologous radioiodinated lipoproteins
into NZW rabbits. Bars represent I SE (where not shown, SE values
fall within data points). The curves were derived from kinetic analysis
of the data using the model solution shown in Fig. 4.
Discussion
We have shown that, as in normal (NZW) rabbits (10), apo B
in all major lipoprotein fractions of WHHL rabbits exists in
particles that lack apo E (B particles) as well as in those that
contain this protein (B,E particles). Furthermore, the presence
of apo E influences the metabolism ofVLDL particles in both
groups of rabbits. Our observations confirm another basic sim-
0 6 12 18 24
Hours After Injection
Figure 3. Removal from whole blood plasma of apo B in B,E and B
particles after injection of autologous radioiodinated lipoproteins into
six WHHL rabbits. Bars represent 1 SE (where not shown, SE values
fall within data points). The curves were derived from kinetic analysis
of the data using the model solution shown in Fig. 5.
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Figure 4. Multicompartmental model of the metabolism of apo B-I00
in NZW rabbits: solution from analyses of data on B,E and B particles
in whole plasma. The concentrations (milligrams per deciliter) of B,E
and B particles of lipoprotein classes in the intravascular compartment
are shown within the circles. Empty circles represent extravascular
compartments for IDL and LDL. Transport rates (mg * dl- I* h-') are
underlined. Small, italicized numbers are rate constants (h-1).
secreted in particles with densities exceeding 1.005 g/ml. The
apo B ofliver perfusates, which was contained almost exclusively
in VLDL, consisted mainly of B,E particles, but like VLDL
isolated from blood plasma, an appreciable fraction (- 30%) of
B particles was also present. These perfusate particles were ob-
tained during single-pass perfusions. However, additional ex-
periments are required to determine the extent to which B,E
and B particles are present in nascent VLDL within liver cells.
Although the VLDL particles produced by the liver seem to
be fundamentally comparable in NZW andWHHL rabbits, their
rates of removal from the blood and conversion to particles of
higher density differ greatly, presumably reflecting the virtual
lack of functional LDL receptors in the latter. Our analysis sug-
gests that the rate of secretion of apo B in WHHL rabbits is
B,E B
VLDL
IDL
LDL
1.017
£31
Figure 5. Multicompartmental model of the metabolism of apo B-100
in WHHL rabbits: solution from analyses of data on B,E and B parti-
cles in whole plasma. Concentrations, rate constants, and transport
rates are shown as in Fig. 4.
Table VI. Conversion Percentages ofapo B-100
between Lipoprotein Fractions
B,E - BE B-yB
Total particles particles
Lipoprotein
fractions NZW WHHL NZW WHHL NZW WHHL
VLDL-IDL 26 56 22 54 62 85
IDL-*LDL 32 72 11 58 47 87
VLDL-LDL 8 40 2 31 29 74
lower than in NZW rabbits, despite the grossly elevated levels
ofapo B in all lipoprotein fractions ofWHHL rabbits. Further-
more, our model solutions suggest that most apo B enters plasma
VLDL as B,E particles in both groups of animals, consistent
with our independent observations of the properties of VLDL
in liver perfusates, although the fraction of B particles in liver
perfusates was somewhat higher than that predicted by the model.
The overall fractional rate of irreversible disposal of IDL as
well as LDL particles was only - 15% ofthat observed in NZW
rabbits, which suggests that 85% of these particles are normally
removed by interaction with LDL receptors. This estimate ex-
ceeds the value of 70% that we (22) and others (3, 4) have
observed from analysis of rates of disappearance of radioiodine
(not exclusively apo B) from whole plasma after injection of
labeled LDL or methyl LDL into normal or WHHL rabbits.
This discrepancy reflects the fact that our estimate of the frac-
tional catabolic rate ofLDL in WHHL rabbits is similar to that
observed by others (3, 4), but our estimate ofthis rate is somewhat
higher for NZW rabbits.
Our initial hypothesis that the fractional rate of irreversible
disposal of apo B in VLDL ofWHHL rabbits would be similar
to that ofIDL and LDL was not consistent with the observation
that the rate of removal from whole plasma of radioiodinated
apo B injected as VLDL was substantially greater than that ob-
served after injection of IDL or LDL. We therefore considered
the possibility that B,E particles in VLDL, which we found to
contain an average ofabout three molecules ofapo E, influenced
the rate of irreversible disposal ofVLDL B,E particles. This hy-
pothesis was supported by the kinetic analysis of the whole
plasma data. The fractional rate of irreversible disposal of B,E
particles in VLDL ofWHHL rabbits was calculated to be fourfold
that ofVLDL B particles, a ratio comparable with that observed
in NZW rabbits.
The mechanism by which B,E particles in VLDL are re-
moved more rapidly than B particles inWHHL rabbits is unclear.
Additional experiments have shown that a small fraction of
VLDL particles, whose diameter exceeds 450 A, is removed rap-
idly from the blood ofWHHL rabbits (unpublished data). VLDL
of this size are also removed more rapidly from the blood of
NZW rabbits, as we have observed previously in humans (23).
Removal of chylomicron remnants from the blood is not im-
paired in WHHL homozygotes (5), and it is possible that large
VLDL are recognized by the chylomicron remnant receptor.
However, the mutation of the LDL receptor gene in WHHL
rabbits has been shown to be ofthe class II variety: LDL receptors
are synthesized, but are not normally glycosylated. The mutation
dictates deletion of four amino acids in one of the putative re-
ceptor-binding domains ofthe receptor protein and it is thought
that this leads to abnormal folding of the protein and greatly
reduces the rate of transport from the endoplasmic reticulum
to the Golgi apparatus (24). A small number of receptor mole-
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cules could reach the cell surface and function in the removal
ofVLDL remnants that contain several molecules ofapo E (pre-
sumably in the liver). Serum and LDL cholesterol levels are
reduced by compactin (25), cholestyramine (26), and partial ileal
bypass (26) in WHHL homozygotes, consistent with stimulation
of functional LDL receptors. However, as in untreated WHHL
rabbits (3, 4) no receptor-mediated clearance of LDL-protein
has been detected in WHHL rabbits after ileal bypass (27). In
the bypassed animals, LDL-protein production was found to be
reduced by 50% (27). Available evidence suggests that terminally
glycosylated LDL receptors in WHHL homozygotes bind LDL
poorly (28). These observations, together with those reported
here, are consistent with the hypothesis that a small number of
LDL receptors on the surface of hepatocytes may function se-
lectively to remove large VLDL remnants, but not smaller ones
or LDL in WHHL homozygotes.
Although the process by which VLDL are removed directly
from the blood is grossly impaired in WHHL rabbits, the pro-
cesses of delipidation by which VLDL are eventually converted
to LDL seem to be intact, so that larger fractions ofVLDL B,E
and B particles are converted to IDL and these in turn to LDL.
This can account for the proportionally greater increase in the
concentration ofapo B in particles ofincreasing density (threefold
in VLDL, fivefold in IDL, and twenty-twofold in LDL; see Table
III). Interestingly, the model suggests that the fractional rate of
conversion of VLDL to IDL was reduced in WHHL rabbits,
but the further conversion of IDL to LDL seemed to proceed
at the same fractional rate as in NZW rabbits, despite the much
larger pool of IDL particles in WHHL rabbits. In addition, the
fractional rate of conversion ofIDL B,E particles to IDL B par-
ticles was much lower in WHHL than NZW rabbits. This lower
rate was required in the model to account for the decreased
proportion of IDL and LDL present as B particles in WHHL
rabbits. Indeed, about two-thirds of all particles that contain apo
B are B,E particles in WHHL rabbits, including one-half of the
LDL. In NZW rabbits, about one-half of particles containing
apo B are B,E particles, and only about one in six LDL particles
contains apo E.
Our observations confirm and extend those of Kita and as-
sociates (2), who first showed that the clearance of apo B of
VLDL from whole plasma is delayed in WHHL rabbits and that
it is converted to a greater extent to IDL and LDL. These ob-
servations have been interpreted to indicate that most VLDL
apo B normally enters the liver as IDL, and that hepatic uptake
of IDL apo B is selectively diminished in WHHL rabbits, so
that a greater fraction is converted to LDL (29). Our observations
indicate that hepatic uptake of VLDL apo B as well as that of
IDL apo B is reduced in WHHL rabbits, so that the increased
formation ofLDL reflects reduced hepatic uptake of its precursor
at the stage ofVLDL as well as IDL (Table VI). The difference
in conversion ofVLDL apo B to that ofIDL is most pronounced
for B,E particles, which presumably reflects the high affinity of
particles that contain several molecules of apo E for the LDL
receptor (30-32). The data ofKita and associates have also been
interpreted to indicate that IDL are normally taken up rapidly
by the liver of normal rabbits (29). Our results indicate that this
is not the case. Rather, IDL particles, even those that contain
apo E, seem to be taken up from the blood no more efficiently
than LDL. Thus, although IDL as well as VXLDL may be thought
of as remnants of lipolytic degradation of nascent VLDL, some
property or properties of IDL make it differ from remnants of
VLDL that remain within the VLDL density range. Since B,E
particles in IDL contain only a single molecule ofapo E, whereas
those of VLDL contain more than one, we suggest that VLDL
remnants have higher affinity for the LDL receptor than IDL
and that this accounts for their differing rates of irreversible dis-
posal.
Our data indicate further that in spite of the virtual lack of
functional LDL receptors in WHHL rabbits, not all VLDL are
converted to LDL. Rather, 60% leave the plasma as VLDL or
IDL. This presumably reflects the fact that receptor-independent
mechanisms mediate the uptake of VLDL and IDL as well as
LDL in WHHL rabbits. In addition, our data suggest that some
VLDL particles are taken up by high affinity mechanisms in
WHHL rabbits.
Simple inspection ofthe B particle tracer data resulting from
LDL and IDL injections in both NZW and WHHL rabbits (Figs.
2 and 3) shows early "flatness," consistent with conversion of
B,E particles to B particles. This pathway was not required for
the VLDL subsystem in NZW and WHHL rabbits and for rea-
sons of simplicity was not included in our model. Within the
context of this model we tested the reverse hypothesis that B
particles are converted B,E particles and found this hypothesis
inconsistent with our data. This inconsistency can be appreciated
in simpler terms by careful inspection of the tracer data. Ifboth
B,E particle conversion to B and B particle conversion to B,E
were to exist-i.e., equilibration-both sets of tracer data should
have the same final slopes, a finding clearly inconsistent with
our B,E and B particle data after injection of LDL, IDL, or
VLDL.2
We conclude that the method of analysis of apo B in whole
plasma that we have employed in our kinetic experiments has
two advantages as compared with the usual method of separat-
ing lipoprotein fractions from recipient animals for analysis. First,
it avoids problems associated with incomplete separation of li-
poprotein fractions by ultracentrifugation (10, 33). Second, it
permits straightforward analysis of heterogeneity related to the
presence or absence of apo E in particles that contain apo B.
Although B,E and B particles can be separated from lipoprotein
fractions separated in the ultracentrifuge, such particles may
have been modified by ultracentrifugal dissociation of apo E
(34-36).
Our method, however, continues to rely upon injection of
lipoproteins that have been subjected to ultracentrifugal forces.
We have attempted to minimize compositional alterations in
the radioiodinated lipoproteins by incubating them with plasma
of the recipient rabbits before injection. We have shown that
the proportion of B,E and B particles in VLDL separated by gel
chromatography and then radioiodinated is similar to that of
ultracentrifuged VLDL, and we have found that the gel-filtered
VLDL have similar kinetic properties to those of ultracentrifuged
VLDL that have been incubated with autologous plasma (10).
We therefore conclude that whatever the extent of ultracentrif-
ugal dissociation of apo E from rabbit VLDL particles, it does
not irreversibly alter their metabolic behavior.
The methods that we have developed for analysis of apo B
2. Consistent with this interpretation is the observation made in a single
experiment in which VLDL-B particles were isolated from 1251I-VLDL
by immunoaffinity chromatography and injected into a rabbit. No labeled
B,E particles could be detected in samples of whole plasma obtained
during the next 24 h. In other experiments in which labeled VLDL-B
particles were mixed with whole plasma in vitro, no conversion to B,E
particles was observed.
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kinetics in rabbit blood plasma should be applicable to other
species. Heterogeneity with respect to presence of apo E also
exists in human lipoproteins that contain apo B (37-41). There-
fore, our approach could yield new insights into human lipo-
protein metabolism.
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